Despite significant advancements in prostate cancer detection and monitoring, current screening and diagnostic methods for prostate cancer, such as prostate specific antigen (PSA) blood testing, digital rectal examination (DRE), and biopsies, present several limitations [3]. The gene discussed is KLK3; the disease is Familial prostate cancer.